Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters
Language
Document Type
Year range
1.
Comment on 'De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine': possible role for Type I interferons.
Awada, B; Abdullah, L; Kurban, M; Abbas, O.
Clin Exp Dermatol ; 47(2): 443, 2022 02.
Article in English | MEDLINE | ID: covidwho-1570537

Subject(s)
COVID-19 , Interferon Type I , Psoriasis , COVID-19 Vaccines , Humans , Psoriasis/chemically induced , SARS-CoV-2
2.
Comment on 'Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence?': Type I interferons as possible link between COVID-19 vaccine and vitiligo.
Abdullah, L; Awada, B; Kurban, M; Abbas, O.
Clin Exp Dermatol ; 47(2): 436-437, 2022 02.
Article in English | MEDLINE | ID: covidwho-1470380

Subject(s)
COVID-19 , Colitis, Ulcerative , Interferon Type I , Vitiligo , COVID-19 Vaccines , Colitis, Ulcerative/complications , Colitis, Ulcerative/drug therapy , Humans , SARS-CoV-2
3.
Response to 'Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence?': Type I interferons as possible link between COVID-19 vaccine and vitiligo
Abdullah, L.; Awada, B.; Kurban, M.; Abbas, O..
Clinical and Experimental Dermatology ; n/a(n/a), 2021.
Article in English | Wiley | ID: covidwho-1408678

ABSTRACT

Abstract We read with interest the article entitled ?Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence?? by Aktas et al.1 The authors describe a 58-year-old man with ulcerative colitis who developed symmetrically distributed vitiligo facial patches around one week after receiving first dose of mRNA vaccine.1 the authors then ponder on the possible underlying immunological mechanism.

SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL